Direct oral anticoagulants compared to low‐molecular‐weight heparin for the treatment of cancer‐associated thrombosis: Updated systematic review and meta‐analysis of randomized controlled trials

BACKGROUND: Low‐molecular‐weight‐heparins (LMWHs) have been established for the treatment of cancer‐associated venous thromboembolism (VTE). Recently published randomized controlled trials (RCTs) have compared direct oral anticoagulants (DOACs) with LMWHs. The aim of this systematic review and meta‐...

Descripción completa

Detalles Bibliográficos
Autores principales: Moik, Florian, Posch, Florian, Zielinski, Christoph, Pabinger, Ingrid, Ay, Cihan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article: Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292654/
https://www.ncbi.nlm.nih.gov/pubmed/32548553
http://dx.doi.org/10.1002/rth2.12359

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7292654/
https://www.ncbi.nlm.nih.gov/pubmed/32548553
http://dx.doi.org/10.1002/rth2.12359

Ejemplares similares